LIST OF TABLES
TABLE 01.AUTOINJECTORS MARKET, BY TYPE, 2019–2027 ($MILLION)
TABLE 02.AUTOINJECTORS MARKET FOR DISPOSABLE AUTOINJECTORS, BY REGION, 2019–2027($MILLION)
TABLE 03.AUTOINJECTORS MARKET FOR REUSABLE AUTOINJECTORS, BY REGION, 2019–2027($MILLION)
TABLE 04.AUTOINJCETORS MARKET, BY APPLICATION, 2019–2027 ($MILLION)
TABLE 05.AUTOINJECTORS MARKET FOR RHEUMATOID ARTHRITIS, BY REGION, 2019–2027($MILLION)
TABLE 06.AUTOINJECTORS MARKET FOR MULTIPLE SCLEROSIS, BY REGION, 2019–2027($MILLION)
TABLE 07.AUTOINJECTORS MARKET FOR ANAPHYLAXIS, BY REGION, 2019–2027($MILLION)
TABLE 08.AUTOINJECTORS MARKET FOR OTHERS, BY REGION, 2019–2027($MILLION)
TABLE 09.AUTOINJECTORS MARKET, BY END USER, 2019–2027 ($MILLION)
TABLE 10.AUTOINJECTORS MARKET FOR HOME CARE SETTINGS , BY REGION, 2019–2027($MILLION)
TABLE 11.AUTOINJECTORS MARKET FOR HOSPITALS & CLINICS, BY REGION, 2019–2027($MILLION)
TABLE 12.AUTOINJECTORS MARKET, BY REGION 2019–2027, ($MILLION)
TABLE 13.NORTH AMERICA AUTOINJECTORS MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 14.NORTH AMERICA AUTOINJECTORS MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 15.NORTH AMERICA AUTOINJECTORS MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 16.NORTH AMERICA AUTOINJECTORS MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 17.U.S. AUTOINJECTORS MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 18.U.S. AUTOINJECTORS MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 19.U.S. AUTOINJECTORS MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 20.CANADA AUTOINJECTORS MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 21.CANADA AUTOINJECTORS MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 22.CANADA AUTOINJECTORS MARKET, BY END USER , 2019–2027, ($MILLION)
TABLE 23.MEXICO AUTOINJECTORS MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 24.MEXICO AUTOINJECTORS MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 25.MEXICO AUTOINJECTORS MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 26.EUROPE AUTOINJECTORS MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 27.EUROPE AUTOINJECTORS MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 28.EUROPE AUTOINJECTORS MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 29.EUROPE AUTOINJECTORS MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 30.GERMANY AUTOINJECTORS MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 31.GERMANY AUTOINJECTORS MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 32.GERMANY AUTOINJECTORS MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 33.FRANCE AUTOINJECTORS MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 34.FRANCE AUTOINJECTORS MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 35.FRANCE AUTOINJECTORS MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 36.UK AUTOINJECTORS MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 37.UK AUTOINJECTORS MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 38.UK AUTOINJECTORS MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 39.ITALY AUTOINJECTORS MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 40.ITALY AUTOINJECTORS MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 41.ITALY AUTOINJECTORS MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 42.SPAIN AUTOINJECTORS MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 43.SPAIN AUTOINJECTORS MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 44.SPAIN AUTOINJECTORS MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 45.REST OF EUROPE AUTOINJECTORS MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 46.REST OF EUROPE AUTOINJECTORS MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 47.REST OF EUROPE AUTOINJECTORS MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 48.ASIA-PACIFIC AUTOINJECTORS MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 49.ASIA-PACIFIC AUTOINJECTORS MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 50.ASIA-PACIFIC AUTOINJECTORS MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 51.ASIA-PACIFIC AUTOINJECTORS MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 52.JAPAN AUTOINJECTORS MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 53.JAPAN AUTOINJECTORS MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 54.JAPAN AUTOINJECTORS MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 55.CHINA AUTOINJECTORS MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 56.CHINA AUTOINJECTORS MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 57.CHINA AUTOINJECTORS MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 58.INDIA AUTOINJECTORS MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 59.INDIA AUTOINJECTORS MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 60.INDIA AUTOINJECTORS MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 61.AUSTRALIA AUTOINJECTORS MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 62.AUSTRALIA AUTOINJECTORS MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 63.AUSTRALIA AUTOINJECTORS MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 64.REST OF ASIA-PACIFIC AUTOINJECTORS MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 65.REST OF ASIA-PACIFIC AUTOINJECTORS MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 66.REST OF ASIA-PACIFIC AUTOINJECTORS MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 67.LAMEA AUTOINJECTORS MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 68.LAMEA AUTOINJECTORS MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 69.LAMEA AUTOINJECTORS MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 70.LAMEA AUTOINJECTORS MARKET, BY COUNTRY, 2019–2027, ($MILLION)
TABLE 71.BRAZIL AUTOINJECTORS MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 72.BRAZIL AUTOINJECTORS MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 73.BRAZIL AUTOINJECTORS MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 74.SAUDI ARABIA AUTOINJECTORS MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 75.SAUDI ARABIA AUTOINJECTORS MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 76.SAUDI ARABIA AUTOINJECTORS MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 77.SOUTH AFRICA AUTOINJECTORS MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 78.SOUTH AFRICA AUTOINJECTORS MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 79.SOUTH AFRICA AUTOINJECTORS MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 80.REST OF LAMEA AUTOINJECTORS MARKET, BY TYPE, 2019–2027, ($MILLION)
TABLE 81.REST OF LAMEA AUTOINJECTORS MARKET, BY APPLICATION, 2019–2027, ($MILLION)
TABLE 82.REST OF LAMEA AUTOINJECTORS MARKET, BY END USER, 2019–2027, ($MILLION)
TABLE 83.AMGEN: COMPANY SNAPSHOT
TABLE 84.AMGEN: OPERATING SEGMENTS
TABLE 85.AMGEN: PRODUCT PORTFOLIO
TABLE 86.AMGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 87.ANTARES : COMPANY SNAPSHOT
TABLE 88.ANTARES: OPERATING SEGMENTS
TABLE 89.ANTARES: PRODUCT PORTFOLIO
TABLE 90.ANTARES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 91.BD: COMPANY SNAPSHOT
TABLE 92.BD: OPERATING SEGMENTS
TABLE 93.BD: PRODUCT PORTFOLIO
TABLE 94.BD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 95.LILLY: COMPANY SNAPSHOT
TABLE 96.LILLY: OPERATING SEGMENTS
TABLE 97.LILLY: PRODUCT PORTFOLIO
TABLE 98.JOHNSON AND JOHNSON : COMPANY SNAPSHOT
TABLE 99.JOHNSON AND JOHNSON: OPERATING SEGMENTS
TABLE 100.JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
TABLE 101.JOHNSON & JOHNSON: NET SALES, 2017–2019 ($MILLION)
TABLE 102.JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENT, 2019 (%)
TABLE 103.JOHNSON & JOHNSON: REVENUE SHARE BY REGION, 2019 (%)
TABLE 104.MYLAN: COMPANY SNAPSHOT
TABLE 105.MYLAN: OPERATING SEGMENTS
TABLE 106.MYLAN: PRODUCT PORTFOLIO
TABLE 107.NOVARTIS: COMPANY SNAPSHOT
TABLE 108.NOVARTIS: OPERATING SEGMENTS
TABLE 109.NOVARTIS: PRODUCT PORTFOLIO
TABLE 110.SHL : COMPANY SNAPSHOT
TABLE 111.SHL : PRODUCT PORTFOLIO
TABLE 112.SHL : KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 113.TEVA: COMPANY SNAPSHOT
TABLE 114.TEVA: OPERATING SEGMENTS
TABLE 115.TEVA: PRODUCT PORTFOLIO
TABLE 116.YPSOMED : COMPANY SNAPSHOT
TABLE 117.YPSOMED : OPERATING SEGMENTS
TABLE 118.YPSOMED : PRODUCT PORTFOLIO
TABLE 119.YPSOMED : KEY STRATEGIC MOVES AND DEVELOPMENTS LIST OF FIGURES
FIGURE 01.SEGMENTATION OF AUTOINJECTORS MARKET
FIGURE 02.TOP WINNING STRATEGIES, BY YEAR, 2017–2020
FIGURE 03.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017–2020 (%)
FIGURE 04.TOP WINNING STRATEGIES, BY COMPANY, 2017–2020
FIGURE 05.TOP PLAYER POSITIONING, 2019
FIGURE 06.HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.HIGH THREAT OF SUBSTITUTION
FIGURE 09.HIGH THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE COMPETITVE RIVARLY
FIGURE 11.GLOBAL AUTOINJECTORS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF AUTOINJECTORS MARKET FOR DISPOSABLE AUTOINJECTORS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF AUTOINJECTORS MARKET FOR REUSABLE AUTOINJECTORS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF AUTOINJECTORS MARKET FOR RHEUMATOID ARTHRITIS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF AUTOINJECTORS MARKET FOR MUTIPLE SCLEROSIS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF AUTOINJECTOR MARKET FOR ANAPHYLAXIS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF AUTOINJECTOR MARKET FOR OTHERS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF AUTOINJECTORS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF AUTOINJECTORS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2019 & 2027 (%)
FIGURE 20.U.S. AUTOINJECTORS MARKET, 2020–2027 ($MILLION)
FIGURE 21.CANADA AUTOINJECTORS MARKET, 2020–2027 ($MILLION)
FIGURE 22.MEXICO AUTOINJECTORS MARKET, 2020–2027 ($MILLION)
FIGURE 23.GERMANY AUTOINJECTORS MARKET, 2020–2027 ($MILLION)
FIGURE 24.FRANCE AUTOINJECTORS MARKET, 2020–2027 ($MILLION)
FIGURE 25.UK AUTOINJECTORS MARKET, 2020–2027 ($MILLION)
FIGURE 26.ITALY AUTOINJECTORS MARKET, 2020–2027 ($MILLION)
FIGURE 27.SPAIN AUTOINJECTORS MARKET, 2020–2027 ($MILLION)
FIGURE 28.REST OF EUROPE AUTOINJECTORS MARKET, 2020–2027 ($MILLION)
FIGURE 29.JAPAN AUTOINJECTORS MARKET, 2020–2027 ($MILLION)
FIGURE 30.CHINA AUTOINJECTORS MARKET, 2020–2027 ($MILLION)
FIGURE 31.INDIA AUTOINJECTORS MARKET, 2020–2027 ($MILLION)
FIGURE 32.AUSTRALIA AUTOINJECTORS MARKET, 2020–2027 ($MILLION)
FIGURE 33.REST OF ASIA-PACIFIC AUTOINJECTORS MARKET, 2020–2027 ($MILLION)
FIGURE 34.BRAZIL AUTOINJECTORS MARKET, 2020–2027 ($MILLION)
FIGURE 35.SAUDI ARABIA AUTOINJECTORS MARKET, 2020–2027 ($MILLION)
FIGURE 36.SOUTH AFRICA AUTOINJECTORS MARKET, 2020–2027 ($MILLION)
FIGURE 37.REST OF LAMEA AUTOINJECTORS MARKET, 2020–2027 ($MILLION)
FIGURE 38.AMGEN: NET SALES, 2017–2019 ($MILLION)
FIGURE 39.AMGEN: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 40.ANTARES: NET SALES, 2017–2019 ($MILLION)
FIGURE 41.ANTARES: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 42.ANTARES: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 43.BD: NET SALES, 2017–2019 ($MILLION)
FIGURE 44.BD: REVENUE SHARE, BY SEGMENT (%)
FIGURE 45.BD : REVENUE SHARE BY REGION, 2019 (%)
FIGURE 46.LILLY REVENUE, 2017-2019 ($MILLION)
FIGURE 47.LILLY: REVENUE SHARE, BY THERAPEUTICS, 2019 (%)
FIGURE 48.LILLY: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 49.MYLAN: NET SALES, 2017–2019 ($MILLION)
FIGURE 50.MYLAN: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 51.NOVARTIS: NET SALES, 2017–2019 ($MILLION)
FIGURE 52.NOVARTIS: REVENUE SHARE, BY SEGMENT, 2019 (%)
FIGURE 53.NOVARTIS: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 54..TEVA: NET SALES, 2017–2019 ($MILLION)
FIGURE 55.TEVA: REVENUE SHARE, BY REGION, 2019 (%)
FIGURE 56.YPSOMED : NET SALES, 2017–2019 ($MILLION